Cargando…

Comparison of antigen and antibody responses in repeat lymphatic filariasis transmission assessment surveys in American Samoa

BACKGROUND: Current WHO recommendations for lymphatic filariasis (LF) surveillance advise programs to implement activities to monitor for new foci of transmission after stopping mass drug administration (MDA). A current need in the global effort to eliminate LF is to standardize diagnostic tools and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Won, Kimberly Y., Robinson, Keri, Hamlin, Katy L., Tufa, Joseph, Seespesara, Margaret, Wiegand, Ryan E., Gass, Katherine, Kubofcik, Joseph, Nutman, Thomas B., Lammie, Patrick J., Fuimaono, Saipale
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862496/ https://www.ncbi.nlm.nih.gov/pubmed/29522520 http://dx.doi.org/10.1371/journal.pntd.0006347

Ejemplares similares

Seroprevalence and Spatial Epidemiology of Lymphatic Filariasis in American Samoa after Successful Mass Drug Administration
por: Lau, Colleen L., et al.
Publicado: (2014)

Potential use of antibodies to provide an earlier indication of lymphatic filariasis resurgence in post–mass drug ad ministration surveillance in American Samoa
por: Cadavid Restrepo, Angela M., et al.
Publicado: (2022)

Prevalence and risk factors associated with lymphatic filariasis in American Samoa after mass drug administration
por: Coutts, Shaun P., et al.
Publicado: (2017)

Detecting and confirming residual hotspots of lymphatic filariasis transmission in American Samoa 8 years after stopping mass drug administration
por: Lau, Colleen L., et al.
Publicado: (2017)

Comparison of Immunochromatographic Test (ICT) and Filariasis Test Strip (FTS) for Detecting Lymphatic Filariasis Antigen in American Samoa, 2016
por: Sheel, Meru, et al.
Publicado: (2021)

Demographic, socioeconomic and disease knowledge factors, but not population mobility, associated with lymphatic filariasis infection in adult workers in American Samoa in 2014
por: Graves, Patricia M., et al.
Publicado: (2020)

Lymphatic filariasis in 2016 in American Samoa: Identifying clustering and hotspots using non-spatial and three spatial analytical methods
por: Wangdi, Kinley, et al.
Publicado: (2022)

Identifying residual transmission of lymphatic filariasis after mass drug administration: Comparing school-based versus community-based surveillance - American Samoa, 2016
por: Sheel, Meru, et al.
Publicado: (2018)

Spatial predictive risk mapping of lymphatic filariasis residual hotspots in American Samoa using demographic and environmental factors
por: Cadavid Restrepo, Angela M., et al.
Publicado: (2023)

Potential strategies for strengthening surveillance of lymphatic filariasis in American Samoa after mass drug administration: Reducing ‘number needed to test’ by targeting older age groups, hotspots, and household members of infected persons
por: Lau, Colleen L., et al.
Publicado: (2020)

Lymphatic Filariasis Elimination in American Samoa: Evaluation of Molecular Xenomonitoring as a Surveillance Tool in the Endgame
por: Lau, Colleen L., et al.
Publicado: (2016)

Molecular Xenomonitoring Using Mosquitoes to Map Lymphatic Filariasis after Mass Drug Administration in American Samoa
por: Schmaedick, Mark A., et al.
Publicado: (2014)

Spatially Explicit Environmental Factors Associated with Lymphatic Filariasis Infection in American Samoa
por: Lemin, Morgan E., et al.
Publicado: (2022)

Notes from the Field: Impact of a Mass Drug Administration Campaign Using a Novel Three-Drug Regimen on Lymphatic Filariasis Antigenemia — American Samoa, 2019
por: Hast, Marisa A., et al.
Publicado: (2020)

Use of Antibody Tools to Provide Serologic Evidence of Elimination of Lymphatic Filariasis in The Gambia
por: Won, Kimberly Y., et al.
Publicado: (2018)

Evaluating Molecular Xenomonitoring as a Tool for Lymphatic Filariasis Surveillance in Samoa, 2018–2019
por: McPherson, Brady, et al.
Publicado: (2022)

Triple-Drug Treatment Is Effective for Lymphatic Filariasis Microfilaria Clearance in Samoa
por: Graves, Patricia M., et al.
Publicado: (2021)

Supporting elimination of lymphatic filariasis in Samoa by predicting locations of residual infection using machine learning and geostatistics
por: Mayfield, Helen J., et al.
Publicado: (2020)

Lymphatic filariasis epidemiology in Samoa in 2018: Geographic clustering and higher antigen prevalence in older age groups
por: Lau, Colleen L., et al.
Publicado: (2020)

Cost-effectiveness analysis of a cluster-randomized, culturally tailored, community health worker home-visiting diabetes intervention versus standard care in American Samoa
por: Huang, Shuo J., et al.
Publicado: (2019)

Lymphatic filariasis endgame strategies: Using GEOFIL to model mass drug administration and targeted surveillance and treatment strategies in American Samoa
por: Shaw, Callum, et al.
Publicado: (2023)

Longitudinal Monitoring of the Development of Antifilarial Antibodies and Acquisition of Wuchereria bancrofti in a Highly Endemic Area of Haiti
por: Hamlin, Katy L., et al.
Publicado: (2012)

Positive-case follow up for lymphatic filariasis after a transmission assessment survey in Haiti
por: Hast, Marisa A., et al.
Publicado: (2022)

Burden of hydrocoele assessed from medical and surgical records in a lymphatic filariasis endemic country, Samoa
por: Ah Leong-Lui, Tile A., et al.
Publicado: (2019)

Scabies prevalence after ivermectin-based mass drug administration for lymphatic filariasis, Samoa 2018–2019
por: Willis, Gabriela A., et al.
Publicado: (2023)

A community survey of coverage and adverse events following country-wide triple-drug mass drug administration for lymphatic filariasis elimination, Samoa 2018
por: Willis, Gabriela A., et al.
Publicado: (2020)

Impact of Ivermectin Mass Drug Administration for Lymphatic Filariasis on Scabies in Eight Villages in Kongwa District, Tanzania
por: Martin, Diana, et al.
Publicado: (2018)

Endpoints for Lymphatic Filariasis Programs
por: Grady, Caroline A., et al.
Publicado: (2007)

Development and Introduction of the Filariasis Test Strip: A New Diagnostic Test for the Global Program to Eliminate Lymphatic Filariasis
por: Pantelias, Anastasia, et al.
Publicado: (2022)

Evolution of the monitoring and evaluation strategies to support the World Health Organization's Global Programme to Eliminate Lymphatic Filariasis
por: Lammie, Patrick J, et al.
Publicado: (2020)

Translating Research into Reality: Elimination of Lymphatic Filariasis from Haiti
por: Lammie, Patrick J., et al.
Publicado: (2017)

The Global Programme to Eliminate Lymphatic Filariasis: History and achievements with special reference to annual single-dose treatment with diethylcarbamazine in Samoa and Fiji
por: Kimura, Eisaku
Publicado: (2011)

Leptospirosis, American Samoa
por: Lau, Colleen L., et al.
Publicado: (2012)

Diagnostics to support elimination of lymphatic filariasis—Development of two target product profiles
por: Won, Kimberly Y., et al.
Publicado: (2021)

Global Programme to Eliminate Lymphatic Filariasis: The Processes Underlying Programme Success
por: Ichimori, Kazuyo, et al.
Publicado: (2014)

Detecting infection hotspots: Modeling the surveillance challenge for elimination of lymphatic filariasis
por: Harris, Julie R., et al.
Publicado: (2017)

MDA—Lymphatic Filariasis
por: Ichimori, Kazuyo
Publicado: (2014)

Urban lymphatic filariasis
por: Simonsen, Paul E., et al.
Publicado: (2012)

Measuring changes in transmission of neglected tropical diseases, malaria, and enteric pathogens from quantitative antibody levels
por: Arnold, Benjamin F., et al.
Publicado: (2017)

Origin, Impact, and Solutions for Lifestyle-Related Chronic Diseases in Samoa and American Samoa
por: Neuendorf, Sable, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ujhvajbdeatvv890h6d0854hrc